Skip to main content

Rachana Singh, MD

Division of Clinical Radiation Oncology

Dr. Singh earned her undergraduate degree in Chemistry at Cornell University in Ithaca, NY prior to completing medical school at Rutgers-Robert Wood Johnson Medical School in Piscataway, NJ. She completed her transitional year internship at Albert Einstein Medical Center in Philadelphia, PA and her residency in Radiation Oncology at the University of Chicago Hospitals in Chicago, IL where she also served as Chief Resident. After graduation, she served as Chief of the Breast Radiation Oncology service at the University of Chicago. Prior to joining Rutgers-CINJ, she was a Clinical Assistant Professor of Radiation Oncology at the University of Pennsylvania hospitals. Dr. Singh currently delivers care specializing in breast, lung, GI, GYN and palliative cases at the Cancer Center at RWJBH-Hamilton Hospital in Hamilton, NJ. She is actively involved in medical student education at Rutgers-Robert Wood Johnson Medical School and co-chairs the Integrative Oncology Services council at RWJBH-Hamilton. A New Jersey native, Dr. Singh enjoys tennis, golf and traveling with her family.


  1. Hathout L, Ennis R, Mattes M et al. The Impact of COVID-19 on Brachytherapy During the Pandemic: A Rutgers-Robert Wood Johnson Barnabas Health Multisite Experience. Advances in Radiation Oncology. January 2021.
  2. Reyhan M, Swann B, Greene K et al. A Cost-Effective Solution to Providing Bio-Positional Feedback To DIBH Patients Treated with Surface Guided Radiation Therapy. Proceeding of the American Association of Physicists in Medicine. October 2021. (Manuscript submitted).
  3. Reyhan M, Swann B, Vergalasova I et al. The Impact of CT Reconstruction Kernels On Atlas Based Automatic Segmentation. Proceeding of the American Association of Physicists in Medicine. July 2020. (Virtual, Poster).
  4. Swann B, Wang X, Reyhan M et al. Creating Embedded Eye Shields in Customized Wax Bolus for Treating Nasal Dorsum Decreases Lens Dose and Streamlines Daily Patient Setup. Proceeding of the American Association of Medical Dosimetrist. March 2020. (Virtual, Poster).
  5. Biswal N, Swann B, Singh R. Urolift as a surrogate for fiducial markers in IGRT planning of prostate cancer in BPH patients. Pract Radiat Oncol. 2017 Dec 24. pii: S1879-8500(17)30382-X. doi: 10.1016/j.prro.2017.11.014.
  6. Zou W, Fisher T, Zhang M et al. Potential of 3D printing technologies for fabrication of electron bolus and proton compensators. J Appl Clin Med Phys. 2015 May 8;16(3):4959. doi: 10.1120/jacmp.v16i3.4959.
  7. Kim LH, Zhang M, Swann B, Rosse M, McKenna MG, and Singh R. Prone setup for testicular non-Hodgkin’s lymphoma radiotherapy [cover image]. Pract Radiat Oncol 2013; 3(2).
  8. Kao J, Conzen SD, Singh R, et al. Concomitant Radiation Therapy and Paclitaxel for Unresectable Locally Advanced and Metastatic Breast Cancer. Results from Two Consecutive Phase I-II Trials. IJROBP 2005; 61: 1045-1053.
  9. Salama JK, Singh R, Heimann R. Does the Number of Tumor Free Axillary Lymph Nodes Impact the Outcome of Node Negative Breast Cancer Patients? CANCER 2005; 103: 664-671.
  10. Singh R, Hellman S, Heimann R. Breast Cancer in the Elderly: Implications for Screening and Treatment. CANCER 2004; 100: 1807-1813.
  11. Singh R. Comparing Breast Cancer Behavior in Women Over 70 to Younger Women: A Natural History Analysis. AJOR Suppl 2004; 1: 10-17.
  12. Taneja N, Davis M, Singh R, et al. H2Ax as a Predictor of Tumor Cell Radiosensitivity. J Biol Chem 2004; 279: 2273-80.
  13. Singh R, Al-Hallaq H, Hong A, et al. The Use of Biological Effective Dose – Dose Volume Histograms for Evaluation of Prostate Brachytherapy Dosimetry. Med Dosim 2003; 28: 255-259.


  • Patient Centered Medicine 1 and 2, Rutgers-Robert Wood Johnson Medical School